Project Grant HT94252410645
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$650K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded The Cleveland Clinic Foundation a $383,740 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the research and development of a "Novel Graft-Localized Drug Delivery Platform for Attenuating Innate Inflammation and Optimizing Immunosuppression in Vascularized Composite Allotransplantation." This project aims to develop innovative medical...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $999,999 Project Grant to The Cleveland Clinic Foundation to conduct research on "Inhibiting Demyelination Rescues Synapse Loss in Multiple Sclerosis." The grant period runs from June 1, 2024 to May 31, 2027. The Cleveland Clinic Foundation, a non-profit academic medical center, will use the funding to carry out innovative biomedical research aimed at developing new treatments...
The Department of the Army Medical Command awarded a $2,602,024 federal Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Cleveland Clinic Foundation in Cleveland, Ohio. The grant, with a performance period from September 30, 2024 to September 29, 2028, will fund research investigating the role of stress in the degradation of intestinal IgA and its impact on intestinal health. The Cleveland Clinic Foundation, a prominent nonprofit academic medical...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The Cleveland Clinic Foundation was awarded a $712,508 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2022 through August 31, 2025. The grant aims to assess the role of glycated apolipoprotein A1 (apoA1) in relation to cognitive complications of diabetes and preclinical Alzheimer's disease. As the primary awardee, Cleveland Clinic will analyze glycated apoA1 levels in plasma samples from...
The Defense Health Agency awarded The Cleveland Clinic Foundation, a non-profit academic medical center, a $893,768 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The two-year grant, effective from September 1, 2023 to August 31, 2025, supports the development of multimodal AI-based solutions to enhance renal cancer patient care. As a leader in medical research, education, and healthcare delivery, The Cleveland Clinic Foundation will leverage its...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $780,357.00 to The Cleveland Clinic Foundation to investigate the novel nuclear localization of the complement regulator CD55 and its impact on disrupting ovarian cancer progression. The 4-year project, starting on May 1, 2025 and concluding on April 30, 2029, aims to advance scientific understanding and develop innovative approaches for addressing this...
The Cleveland Clinic Foundation will receive $942,000 under a three-year Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Catalog of Federal Domestic Assistance number 12.420. The funding will support research investigating the role of a novel inhibitory receptor complex in driving T cell dysfunction and therapeutic resistance to immunotherapies in lung cancer....
This $1,280,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) funds research conducted by The Cleveland Clinic Foundation to investigate how the NF-I/A transcription factor regulates an HIF-independent fatty acid metabolism program in kidney cancer. The award, with a performance period from September 1, 2024 to August 31, 2028, supports the Cleveland Clinic Foundation's research to develop innovative medical solutions for...
This federal Project Grant award of $3,491,232 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation. The funding supports the development and evaluation of an augmented reality-based "Return-to-Duty (READY) System" to objectively assess service member performance following mild traumatic brain injury. The project, titled "Troop Readiness Evaluation with an Augmented Reality READY...